The WDFY3 gene encodes a large multidomain scaffolding protein implicated in the selective degradation of ubiquitinated protein aggregates by autophagy. A WDFY3 missense variant in the PH domain of the protein was reported in 2016 in a large family with autosomal dominant microcephaly and mild to moderate intellectual disability (Kadir et al., PMID: 27008544). Since then, several mostly de novo variants in WDFY3 have been reported, including nonsense, frameshift, splice, and missense variants. Affected individuals present with developmental delay, intellectual disability, autism spectrum disorder, hypotonia, seizures, and abnormal head size, either microcephaly or macrocephaly (PMIDs: 27824329, 28263302, 30564305, 31130284, 31327001). It has been suggested that WDFY3 haploinsufficiency leads to macrocephaly or large-normal head size, while missense variants in the PH domain of WDFY3 cause microcephaly (two such variants reported) through opposing effects on the Wnt pathway (PMID: 31327001). Although this hypothesis appears to be supported by a transgenic fly model overexpressing a human WDFY3 mutant (PMID: 27008544) and several Wdfy3 loss-of-function mouse models (PMID: 25198012, 27648578, 31327001), further evidence is needed to clarify the effect of WDFY3 variants on head size and the mechanisms involved.
In summary, there is definitive evidence supporting the relationship between WDFY3 and autosomal dominant syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on January 19, 2022 (SOP Version 8).
Data provided by the ClinGen Prenatal GCEP from April 8, 2025 secondary analysis:
There is no clear evidence for prenatal phenotypes in WDFY3-syndromic intellectual disability at the time of this curation. The only reported prenatal phenotype is hypoplastic left heart found in a fetus with a de novo WDFY3 frameshift variant (PMID: 33898534). No cases with fetal hydrops have been reported.
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.